Hims & Hers Health, Inc. (HIMS)

Market Cap	2.54B
Revenue (ttm)	872.00M
Net Income (ttm)	-23.55M
Shares Out	205.87M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	179.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,548,786
Open	12.30
Previous Close	12.41
Day's Range	12.14 - 12.63
52-Week Range	5.65 - 17.16
Beta	0.91
Analysts	Buy
Price Target	13.91 (+12.72%)
Earnings Date	May 6, 2024

About HIMS

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supp...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2017
• Employees: 1,046
• Stock Exchange: NYSE
• Ticker Symbol: HIMS

Financial Performance

In 2023, HIMS's revenue was $872.00 million, an increase of 65.49% compared to the previous year's $526.92 million. Losses were -$23.55 million, -64.15% less than in 2022.

Analyst Forecast

According to 11 analysts, the average rating for HIMS stock is "Buy." The 12-month stock price forecast is $13.91, which is an increase of 12.72% from the latest price.

Price Target

$13.91

(12.72% upside)

Analyst Consensus: Buy